GAUTAM DESAI: Open Payments
NPI 1245242510 · WEST LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,253 in 115 payments from 21 companies in 2025. Trend: 2023 $754 · 2024 $1,354 · 2025 $2,253
Food & beverage: $2,253
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 22 | $329 |
| Insulet Corporation | 7 | $267 |
| Novo Nordisk Inc | 11 | $264 |
| ABBVIE INC. | 15 | $236 |
| Amgen Inc. | 13 | $222 |
| Exact Sciences Corporation | 8 | $172 |
| AstraZeneca Pharmaceuticals LP | 7 | $102 |
| Mannkind Corporation | 2 | $96 |
| Kowa Pharmaceuticals America, Inc. | 5 | $79 |
| GlaxoSmithKline, LLC. | 4 | $74 |
Products named: Korlym, OMNIPOD, Cologuard Collection Kit, OTEZLA, VRAYLAR, Ozempic, AFREZZA, ZORYVE.
Industry payments across NJ — which companies pay providers there.
